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FoxO3Hepatocellular apoptosis is an important pathological entity of alcoholic liver disease. Previously, we have
shown that globular adiponectin (gAcrp) protects liver cells from ethanol-induced apoptosis by modulating
an array of signaling pathways. In the present study, we investigated the role of autophagy induction by
gAcrp in the suppression of ethanol-induced apoptosis and its potential mechanism(s) in liver cells. Here,
we demonstrated that gAcrp signiﬁcantly restores ethanol-induced suppression of autophagy-related
genes, including Beclin-1 and microtubule-associated protein light chain (LC3B) both in primary rat hepato-
cytes and human hepatoma cell line (HepG2). Globular adiponectin also restored autophagosome formation
suppressed by ethanol treatment in HepG2. Furthermore, inhibition of gAcrp-induced autophagic process by
knock-down of LC3B prevented protection from ethanol-induced apoptosis. In particular, the autophagic
process induced by gAcrp was involved in the suppression of ethanol-induced activation of caspase-8 and
expression of Bax. Moreover, knock-down of AMPK by small interfering RNA (siRNA) blocked gAcrp-induced
expression of genes related to autophagy, which in turn prevented protection from ethanol-induced apoptosis,
suggesting that AMPK plays an important role in the induction of autophagy and protection of liver cells by
gAcrp. Finally, we also showed that gAcrp treatment induces translocation of the forkhead box O member
protein, FoxO3A, into the nucleus, which may play a role in the induction of autophagy-related genes. Taken
together, our data demonstrated that gAcrp protects liver cells from ethanol-induced apoptosis via induction
of autophagy. Further, the AMPK-FoxO3A axis plays a cardinal role in gAcrp-induced autophagy and subsequent
inhibition of ethanol-induced apoptosis.
© 2013 Elsevier B.V. All rights reserved.1. Introduction
Alcoholic liver disease (ALD) developed by excessive and chronic
alcohol consumption is a major cause of chronic liver disease and
accompanied by various pathogeneses, including steatosis, inﬂamma-
tion, ﬁbrosis and cirrhosis [1]. Ethanol treatment is also well known
to induce excessive and sustained hepatocellular apoptosis. Recent
studies have highlighted that alcohol- and/or its metabolite-induced
generation of reactive oxygen species (ROS) along with inﬂammatory
mediators plays a crucial role in the activation and release of pro-
apoptotic molecules, leading to massive cellular organelle damage
in the liver [2,3]. This is considered an important pathological event
in the progression of human alcoholic liver disease and emerging
evidence suggests that therapeutic modulation of dysregulated apo-
ptosis may constitute a critical remedial approach for the treatment
of ALD. Apoptosis of liver cells is regulated by both the extrinsic path-
way integrated by caspase-8 and the intrinsic pathway regulated by
Bcl-2 family proteins, such as Bcl-2 and Bax. Both of these pathways
ultimately activate caspase-3, the ﬁnal executioner of apoptotic cell+82 53 810 4654.
rights reserved.death [4], and are implicated in ethanol-induced apoptosis in hepatic
cells.
Autophagy, a different type of self-destructive process from apopto-
sis, is the major cellular pathway for the degradation of damaged pro-
teins and cytoplasmic organelles. The canonical process of autophagy
involves the formation of double-membraned autophagosomes, which
envelop potential toxic substrates and ﬁnally fuse with lysosomes for
degradation [5,6]. It is an evolutionarily conserved process in eukary-
otes and acts as a crucial process in the development and differentiation
of cells and themaintenance of cytoplasmic organelle turnover [5]. Even
if autophagywas observed in dying cells (i.e., autophagic cell death) and
has been classiﬁed as type 2 programmed cell death (apoptosis is type
1) [7], emerging evidence has shown that the autophagic process pro-
vides an efﬁcient cellular defensemechanism and plays a cytoprotective
role in various stressful conditions, such as starvation, endoplasmic
reticulum stress and pathogen infection [8,9]. Furthermore, dysregulated
modulation of autophagy accompanies various pathophysiologic condi-
tions, including cancer [10].
Growing evidence also highlights that the cytoprotective function
of autophagy is mediated at least in part by negative modulation of
apoptosis [8,11]. For example, activation of the autophagic process
leads to negative modulation of Bax [12,13]. Also, Beclin-1 mediated
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apoptosis [14]. Recent studies have reported that chronic ethanol
consumption causes down-regulation of autophagy-related proteins,
including beclin-1 and micro-tubule associated protein light chain
(LC3-II) [15], and inhibits autophagy of liver cells through inhibition of
AMPK activity [16]. Moreover, activation of autophagy reduces ethanol-
induced hepatotoxicity in mice [17]. In addition, the degradation and
removal of damaged and unnecessary constituents in the hepatocellular
environment through autophagy have been shown to limit ethanol-
induced hepatotoxicity and promote survival alongwith proper cellular
functioning [18], suggesting that dysregulated autophagy is involved in
the pathogenesis of alcohol-induced liver disease.
Adiponectin predominantly secreted from adipose tissue plays a
key role in the regulation of various biological responses, including
lipid and glucose metabolism [19] and also possesses potent anti-
inﬂammatory, anti-diabetic, anti-atherogenic and anti-apoptotic
properties [20–22]. In addition, adiponectin has been shown to
reduce liver damage from chronic alcohol consumption [23]. As
mentioned earlier, apoptosis of liver cells is a critical feature of ALD
and it has recently been shown that globular adiponectin (gAcrp)
prevents ethanol-induced apoptosis of liver cells [24], suggesting
that down-regulation of apoptotic signaling is responsible for the
protective effect of adiponectin on ethanol-induced liver injury.
While a growing body of evidence suggests that autophagy negatively
regulates the apoptotic process in various cellular conditions [8] and
adiponectin possesses potent anti-apoptotic properties, the effect of
adiponectin on autophagic process and its role in the suppression of
ethanol-induced apoptosis have not been explored yet.
AMP-activated protein kinase (AMPK), a conserved energy sensor
in eukaryotic cells, is well recognized as a key mediator of various
biological responses induced by adiponectin [25]. In addition to its
established role in metabolism, the AMPK signaling pathway has been
intensively studied in recent years because it coordinates metabolism
with both apoptosis and autophagy [26]. Ethanol consumption has
been linked to reduced intracellular AMPK activity in the liver [27].
Furthermore, decreased AMPK activity by ethanol has been shown to
inhibit autophagy in liver cells, which ultimately promotes hepatocyte
cell death [18,28,29]. With regards to mediation of various biological
responses byAMPK signaling, AMPK regulates the activities of a number
of transcription factors, including the peroxisome proliferator-activated
receptor (PPAR) gamma, PPAR-alpha, cAMP response element-binding
(CREB), and nuclear factor (erythroid-derived 2)-like 2 (Nrf2) [30].
Among these, the forkhead box O (FoxO) family of transcription factors,
particularly FoxO3A, has been shown to induce expression of genes
related to autophagy [30–32].
Thus, to better understand the mechanisms underlying suppression
of apoptosis by adiponectin in ethanol-treated liver cells, herein we
investigated the role of autophagy in the suppression of apoptosis by
globular adiponectin (gAcrp). In the present study, we have demon-
strated for the ﬁrst time that gAcrp activates the autophagy process
in a human liver cell line and this is implicated in the suppression
of ethanol-induced apoptosis. Furthermore, we have identiﬁed that
the AMPK-FoxO3A signaling pathway plays a critical role in gAcrp-
induced expression of genes related to autophagy.
2. Material and methods
2.1. Materials
All the cell culture reagents used in the present study were procured
from Hyclone laboratories (South Logan, Utah, USA). Recombinant
human globular adiponectin (gAcrp) was obtained from Peprotech Inc.
(Rocky Hill, NJ, USA). Absolute ethanol was purchased from Merck
chemicals (Whitehouse Station, NJ, USA). Caspase-3 and caspase-8
activity assay kits were purchased from Promega Corporation (Madison,
WI, USA). Rapamycin and antibodies against Beclin-1, LC 3B andβ-actin were obtained from Cell Signaling Technology Inc. (Beverly,
MA, USA). Goat anti-rabbit secondary antibody was obtained from
Pierce biotechnology (Rockford, IL, USA). 3-Methyladenine (3-MA), a
class III phosphoinositol 3-kinase (PI3K) inhibitor, and used as a selec-
tive inhibitor of autophagy,was obtained fromTocris Bioscience (Bristol,
UK). All other chemicals were obtained from Sigma-Aldrich (St Louis,
MO, USA) unless mentioned elsewhere.
2.2. Isolation and culture of rat primary hepatocytes
All the animal experiments were performed in accordance with
the guidelines for Animal Care and Use Committee at Yeungnam
University. Male Sprague–Dawley rats, weighing 225–250 g, were
used for the isolation of hepatocytes, via a two-step collagenase perfu-
sion method [33].Cell viability for isolated hepatocytes was assessed
by trypan blue exclusion, which was found to be above 90%. Isolated
rat hepatocytes were then suspended in William's medium E (Sigma)
and incubated in collagen-coated 6-well culture plates. After overnight
incubation, the cells were treatedwith gAcrp in the absence or presence
of ethanol for the indicated time points as mentioned in the ﬁgure
legends.
2.3. Cell cultures
HepG2 cells, a human hepatoma cell line purchased from American
TypeCulture Collection (Rockville,MD,USA),were routinely cultured in
Dulbecco's Modiﬁed Eagle Medium (DMEM), supplemented with 10%
fetal bovine serum (FBS) and 1% penicillin–streptomycin along with
0.1% amphotericin at 37 °C in an incubator with 5% CO2.
2.4. MTS assay
For the determination of cell viability, HepG2 cells were seeded in
96 well plates and transfected with siRNA targeting LC3B for 48 h,
followed by ethanol treatment in the absence or presence of gAcrp.
Finally, cell viability was monitored after addition of MTS solution
via a Versamax microplate reader (Sunnyvale, CA,USA) by measuring
absorbance at 490 nm as described previously [24].
2.5. Caspase-3 and caspase-8 activity assay
Caspase-3 and caspase-8 activities were determined using Caspase-
Glo 3/7 and Caspase-Glo 8 assay kits (Promega Corporation, Madison,
USA) respectively as described previously [24]. In brief, primary rat
hepatocytes and HepG2 cells were seeded at a density of 1 × 105 cells
per well in 2 ml culture media as described above in 6-well plates
and 35 mm dishes respectively. The cells were incubated overnight
followed by treatment with the indicated concentrations of globular
adiponectin for 24 h followed by treatment with ethanol (50 mM) for
additional 24 h. Finally, 100 μl of cell lysates was used in duplicate for
the measurement of luminescence from the cleavage of luminogenic
substrate Ac-DEVD-pNA and LETD sequence for caspase-3 and caspase-
8 activities respectively with a micro-plate reader (Flurostar Optima,
BMG Labtech, Ortenberg, Germany).
2.6. RNA isolation, reverse transcription (RT) and quantitative PCR
(qPCR)
For themeasurement of mRNA levels of genes of interest, total RNAs
were isolated from the cultured cell with Qiagen lysis solution (Qiagen,
Maryland, USA) according to the manufacturer's instructions. One
microgram of total RNA was reverse transcribed for the synthesis of
cDNA. Real time-PCR ampliﬁcation was then performed with a Roche
LightCycler 2.0 (Mannheim, Germany) using the absolute QPCR SYBR
green capillary mix AB gene system (Thermoscientiﬁc, UK) at 95 °C
for 15 s, 56 °C for 30 s, and 72 °C for 45 s. The primer sequences used
Table 2
Sequences of small interfering RNA used in transfection.
Target gene Primer Nucleotide sequence
LC3B F
R
5′-GACUGUCUCGUUUAGACUG-3′
5′-CAGUCUAAACGAGACAGUC-3′
AMPK alpha-1 F
R
5′-CUGAGUUGCAUAUACUGUA-3′
5′-UACAGUAUAUGCAACUCAG-3′
FoxO3A F
R
5′-GACGAUGAUGCGCCUCUCU-3′
5′-AGAGAGGCGCAUCAUCGUC-3′
Scrambled control F
R
5′-CCUACGCCACCAAUUUCGU-3′
5′-ACGAAAUUGGUGGCGUAGG-3′
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of target mRNA was determined as described previously [24] via
comparative threshold (Ct) method after normalizing target mRNA
Ct values to those for glyceraldehyde-3-phosphate dehydrogenase
GAPDH (ΔCt) which was taken as a housekeeping gene.
2.7. Transient transfection with small interfering RNA (siRNA)
HepG2 cells were initially seeded in a six well plate at a density of
2 × 105 cells perwell in 2 ml culturemedia. After overnight incubation,
cells were transfected with corresponding siRNA of target gene or
scrambled control siRNA in 1 ml growth medium with Hiperfect trans-
fection reagent (Qiagen) according to the manufacturer's instructions.
The transfection efﬁciency was assessed by qRT-PCR after 24–48 h of
transfection, followed by gAcrp treatment for the indicated time points.
The siRNA duplexes were chemically synthesized by Bioneer (Daejeon,
South Korea) and used for the study (Table 2).
2.8. Preparation of cellular extracts and Western blot analysis
Primary hepatocytes and HepG2 cells were seeded in 6-well plates
and 60 mm dishes respectively at the density of 1 × 106 cells per
well. After overnight incubation, cells were treated with ethanol in
the absence or presence of gAcrp for the indicated time points. Total
proteins were then isolated after lysing cells in RIPA buffer containing
halt protease inhibitor cocktail (Thermoscientiﬁc, Rockford, USA) as
described previously [24]. For the preparation of nuclear and cytosolic
fractions, the cells were washed in ice-cold PBS twice, and then lysed
using subcellular fractionation buffer (250 mM sucrose, 20 mMHEPES
pH 7.4, 10 mM KCl, 1.5 mM MgCl2, 1 mM EDTA, 1 mM EGTA, 1 mM
DTT, and halt protease inhibitor cocktail). The cellular lysates were
then passed through 25G needle 10–15 times for homogenization
followed by centrifugation at 720 g for 5 min at 4 °C to remove the
nuclear pellet. The remaining supernatants were centrifuged at
10,000 g for 15 min. The cellular debris was then removed and the
obtained supernatants were taken as cytosolic fractions. For the prepa-
ration of nuclear fraction, nuclear pellets were lysed in RIPA buffer for
1 h followed by centrifugation at 10,000 g for 15 min and the obtained
supernatants were taken as nuclear fraction. All the procedures men-
tioned above were carried out on ice. Cytosolic and nuclear fractions
were stored at −70 °C until further use. For immunoblot analysis,
30–60 μg of solubilized proteins was then loaded and resolved by
10–15% SDS-PAGE. The proteins were then transferred to PVDF mem-
branes, blocked, incubated with the designated primary antibodies,
washed and incubated with the secondary HRP-labeled antibody.
Chemiluminescent images of the blots were ﬁnally captured using a
Fujiﬁlm LAS-4000 mini (Fujiﬁlm, Tokyo, Japan). The membranes were
then stripped and reprobed with β-actin or lamin b1 antibody as the
loading control.
2.9. Confocal microscopic analysis
For confocalmicroscopic analysis, HepG2 cells were transfectedwith
enhanced green ﬂuorescent protein (eGFP)-LC3 expression plasmid
using Fugene HD transfection reagent (Promega, Madison, USA) in
cover glass bottom dishes according to the manufacturer's instructions.Table 1
Sequences of human primers used in quantitative RT-PCR.
Target gene Primer Nucleotide sequence
GAPDH F
R
5′-ACCACAGTCCATGCCATCAC-3′
5′-TCCACCACCCTGTTGCTGTA-3′
Beclin-1 F
R
5′-CTTACCACAGCCCAGGCGAAAC-3′
5′-GCCAGAGCATGGAGCAGCAA-3′
LC3B F
R
5′-ACCATGCCGTCGGAGAAG-3′
5′-GGTTGGATGCTGCTCTCGAA -3′After 36 h of transfection, cells were treated with gAcrp in the absence
or presence of ethanol for the indicated time. Cells were ﬁxed with 4%
paraformaldehyde solution and ﬁnally, the confocal images were
captured using an A1 Confocal Laser Microscope System (Nikon Corp.,
Tokyo, Japan). For quantiﬁcation of autophagic puncta, confocal images
obtained from triplicate experiments were used and expressed as
percentage of cells with GFP-LC3 dots obtained from at least 100 cells
with Image Inside software version 2.32.2.10. Statistical analysis
Values are presented as mean ± SEM of at least three experiments.
Data were analyzed by one-way analysis of variance (ANOVA) and
Tukey's multiple comparison tests using GraphPad prism software
version 5.01 (California, USA). Differences between groups were con-
sidered to be signiﬁcant at p b 0.05.3. Results
3.1. Globular adiponectin restores ethanol-suppressed expressions of
autophagy-related proteins in HepG2 and primary hepatocytes isolated
from rat
Ethanol treatment has been shown to decrease expression of
autophagy-related proteins in the liver.Wehypothesize that adiponectin
restores suppression of autophagy-related proteins by ethanol in liver
cells. To examine this, we ﬁrst conﬁrmed inhibitory effects of ethanol
on the expression of proteins related to autophagy in human hepatoma
cell line (HepG2 cells). In these experiments, we measured the expres-
sion of beclin-1, which is considered essential for the formation of
autophagosomes (required for the initial stage of autophagy) [34], and
microtubule-associated protein light chain 3B (LC3B), which is regarded
as a major constituent of autophagosomes (essential for relatively late
stage of autophagic process) [5]. As shown in Fig. 1A, ethanol treatment
decreased the expression of beclin-1 both at the mRNA and protein
levels in a dose-dependent manner. It also decreased LC3B mRNA and
LC3 II protein expression levels (Fig. 1B) in a dose-dependent manner.
Next, to investigate the effects of gAcrp on the expression of autophagy-
related proteins, cells were treated with gAcrp for the indicated times.
Interestingly, gAcrp treatment signiﬁcantly increased mRNA expres-
sions of beclin-1 and LC3B (Fig. 1C) in a time-dependent manner.
Finally, the effects of gAcrp on restoration of ethanol-suppressed
autophagy-related proteins were examined. As indicated in Fig. 1D,
gAcrp dose-dependently restored ethanol-inhibited beclin-1 mRNA
and protein expression. In addition, LC3B mRNA and LC3 II protein
levels were also returned to the normal level by gAcrp treatment in
HepG2 cells (Fig. 1E). Similar results were also observed in primary
hepatocytes isolated from rat. As shown in Fig. 1, ethanol treatment
reduced expression of beclin-1 (Fig. 1F) and LC3 (Fig. 1G) in rat hepato-
cytes, which was restored by pretreatment with gAcrp. All these data
indicate that gAcrp restores expression of autophagy-related genes
suppressed by ethanol in liver cells.
Beclin-1
β-actin
Ethanol  (mM)
0 25 50 100
EtOH (mM) 0 25 50 100
*
*
12
0.8
0.4
0.0
B
ec
lin
-1
/G
AP
DH
 m
RN
A
EtOH (mM) 0 25 50 100
*
* LC3-I
LC3-II
0 25 50 100
Ethanol  (mM)
β-actin
1.2
0.8
0.4
0.0
LC
3B
/G
AP
DH
 m
RN
A
(re
lat
ive
 to
 co
nt
ro
l)
A
B
gAcrp (1µg/ml) 0 3 8 24
*
h gAcrp (1µg/ml) 0
*
3 8 24 h
2.0
1.5
1.0
0.5
0.0
B
ec
lin
-1
/G
AP
DH
 m
RN
A
(re
lat
ive
 to
 co
nt
ro
l)
(re
lat
ive
 to
 co
nt
ro
l)
(re
lat
ive
 to
 co
nt
ro
l)
2.5
2.0
1.5
1.0
0.5
0.0
LC
3B
/G
AP
DH
 m
RN
A
(re
lat
ive
 to
 co
nt
ro
l)
Beclin-1
β-actin
β-actin
EtOH (50 mM)
gAcrp (µg/ml)
-
-
+
-
+
0.1
+
1
-
1
-
-
EtOH (50 mM)
gAcrp (µg/ml)
+
-
+
0.1
+
1
*
#1.0
0.8
0.6
0.4
0.2
0.0
B
ec
lin
-1
/G
AP
DH
 m
RN
A
C
D
LC3-II
LC3-I
EtOH 50 mM -
-
+
-
+
0.1
+
1
EtOH 50 mM
gAcrp (µg/ml)
-
-
+
-
+
0.1
+
1
*
#
#
gAcrp (µg/ml)
1.5
1.0
0.5
0.0
LC
3B
/G
AP
DH
 m
RN
A
E
2114 S. Nepal, P.-H. Park / Biochimica et Biophysica Acta 1833 (2013) 2111–2125
EtOH 50 mM
gAcrp (µg/ml)
-
-
+
-
+
0.1
+
1
-
1
*
#
#
1.5
1.0
0.5
0.0
B
ec
lin
-1
/G
AP
DH
 m
RN
A
(re
lat
ive
 to
 co
nt
ro
l)
F
LC3-I
LC3-II
β-actin
EtOH 50 mM
gAcrp (µg/ml)
-
-
+
-
+
0.1
+
1
-
1
G
Fig. 1. Effects of globular adiponectin on the expression of autophagy-related proteins suppressed by ethanol. (A) Effect of ethanol on beclin-1 expression. Cells were incubated with
the indicated concentration of ethanol for 24 h. (left panel) Beclin-1 mRNA expression level was assessed by qRT-PCR as described in the Material and methods section and the level
was normalized to that of GAPDH mRNA. Values represent fold increase in comparison to cells not treated with ethanol and are expressed as mean ± SEM (n = 3). ⁎P b 0.05
compared to the cells not treated with ethanol. (right panel) Beclin-1 protein expression level was determined by Western blot analysis. β-actin was used as an internal control.
Images are representative of three independent experiments that showed similar results. (B) Effect of ethanol on LC3 expression. Cells were incubated with indicated concentration
of ethanol for 24 h. (left panel) LC3B mRNA expression level was measured by qRT-PCR as described previously and normalized to GAPDH mRNA. Values represent fold increase
compared to cells not treated with ethanol and are expressed as mean ± SEM (n = 4). ⁎P b 0.05 compared to cells not treated with ethanol. (right panel) LC3 II protein expression
level was determined by Western blot analysis. β-actin was used as an internal control. Images are representative of three independent experiments that showed similar results.
(C) Cells were incubated with gAcrp (1 μg/ml) for the indicated time periods. (left panel) Beclin-1 mRNA expression was analyzed by qRT-PCR as described previously and the level
was normalized to GAPDHmRNA. Values represent fold increase relative to control and are expressed as mean ± SEM, n = 4. ⁎P b 0.05 compared with control group. (right panel)
Cells were incubated with gAcrp (1 μg/ml) for the indicated time periods. LC3B mRNA expression was analyzed by qRT-PCR as described previously and normalized to GAPDH
mRNA. Values represent fold increase relative to control and are expressed as mean ± SEM, n = 3. ⁎P b 0.05 compared with control group. (D) Effect of gAcrp on the expression
of beclin-1 suppressed by ethanol. Cells were preincubated with the indicated concentrations of gAcrp for 24 h followed by stimulation with ethanol for additional 24 h. (left panel)
Beclin-1 mRNA expression was analyzed by qRT-PCR as described previously and normalized to GAPDH mRNA. Values are presented as mean ± SEM (n = 4) ⁎P b 0.05 compared
to cells not treated with ethanol, #P b 0.05 compared to ethanol-treated group. (right panel) Total cell lysates were prepared as described in the Material and methods section and
used for the measurement of beclin-1 protein level by Western blot analysis. Representative image from three independent experiments is shown along with β-actin for internal
loading control. (E) Effect of gAcrp on expression of Beclin-1 and LC3B suppressed by ethanol. HepG2 cells were pretreated with the indicated concentrations of gAcrp for 24 h
followed by incubation with ethanol for additional 24 h. (left panel) LC3B mRNA expression was analyzed by qRT-PCR as described previously and normalized to GAPDH mRNA.
Values are presented as mean ± SEM (n = 3) ⁎P b 0.05 compared to cells not treated with ethanol, #P b 0.05 compared to ethanol-treated group. (right panel) Total cell lysates
were prepared as described previously and used for the measurement of LC3II protein level by Western blot analysis. Representative image from three independent experiments is
shown along with β-actin for internal loading control. (F) Effect of gAcrp on expression of Beclin-1 suppressed by ethanol in primary rat hepatocytes. Hepatocytes were isolated
from rat and treated with the indicated concentrations of gAcrp for 24 h followed by incubation with ethanol for additional 24 h. Beclin-1 mRNA expression was analyzed by
qRT-PCR as described previously. Values are presented as mean ± SEM (n = 3) ⁎P b 0.05 compared to cells not treated with ethanol, #Pb0.05 compared to ethanol-treated
group. EtOH: Ethanol, gAcrp: globular adiponectin. (G) Effect of gAcrp on protein expression of LC3 suppressed by ethanol in primary rat hepatocytes. Hepatocytes were isolated
from rat and treated with gAcrp for 24 h followed by incubation with ethanol for additional 24 h. LC3 protein expression levels were analyzed byWestern blot analysis as described
previously.
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to the suppression of ethanol-induced apoptosis
Wenext conﬁrmed gAcrp-induced expression of LC3 II protein inside
cells by transfection of eGFP-LC3 plasmid under confocal microscopy.
As depicted in Fig. 2A, ethanol treatment signiﬁcantly decreased LC3 II
expression (LC3 dots) and pretreatment with gAcrp restored LC3 II
expression (punctuated pattern), indicating the effect of gAcrp on
autophagosome formation in ethanol-treated HepG2 cells. Next, we
assessed whether gAcrp induces autophagic ﬂux in these conditions.
For this, cells were pretreated with Baﬁlomycin A1, a speciﬁc
autophagosome-lysosome inhibitor, followed by ethanol treatment in
the absence or presence of gAcrp. Interestingly, as depicted in Fig. 2B,
pretreatment with Baﬁlomycin A1 further increased LC3 II protein
levels, suggesting that gAcrp induces autophagic ﬂux in HepG2 cells.
Our lab data also revealed that gAcrp decreased expression of p62
(SQSTM1/sequestosome 1), which is a marker of autophagic ﬂux [35]
(data not shown),strongly suggesting that gAcrp not only increases
LC3 II protein levels but also activates autophagic ﬂux in HepG2 cells.Recent studies have shown a potential linkage between autophagy and
apoptosis in various experimental conditions [8,11]. To elucidatewhether
gAcrp-induced autophagy is linked to ethanol-induced apoptosis, we
investigated the effect of gAcrp on ethanol-induced caspase-3 activation.
As shown in Fig. 2C, ethanol-induced caspase-3 activation was returned
to the normal level by gAcrp in HepG2 cells and primary hepatocytes
(Fig. 2D), whichwas consistentwith previous observations and indicated
a correlation between induction of autophagy and suppression of apo-
ptosis by gAcrp.
3.3. Globular adiponectin-induced autophagy contributes to the suppression
of ethanol-induced apoptosis in HepG2 cells
To further investigate the role of autophagy induction by gAcrp in the
suppression of ethanol-induced apoptosis, we ﬁrst measured the effect
of rapamycin, an inhibitor of mammalian target of rapamycin (mTOR),
which is known to induce autophagy on ethanol-induced caspase-3
activation. As shown in Fig. 3A, pretreatment of cells with rapamycin
signiﬁcantly inhibited ethanol-induced activation of caspase-3, indicating
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Fig. 2. Effects of ethanol and gAcrp on autophagosome formation and its inverse relationship with apoptosis. (A) Cells were transfected with eGFP-LC3 expression plasmid for 36 h.
Cells were then pretreated with gAcrp for 24 h followed by stimulation with ethanol for additional 24 h. GFP-LC3 was viewed with A1 Confocal Laser Microscope System as
described in the Material and methods section. Representative images from three independent experiments are shown along with quantitation of LC3 dots on the lower panel.
Values are expressed as percentage of cells with GFP-LC3 dots obtained from at least 100 cells. C: Control, E: ethanol, gAcrp: Globular adiponectin.⁎P b 0.05 compared with cells
not treated with ethanol; #P b 0.05 compared with cells treated with ethanol. (B) Cells were pretreated with Baﬁlomycin A1, a speciﬁc autophagosome-lysosome inhibitor,
followed by gAcrp treatment in the absence or presence of ethanol. LC3 II protein expression level was determined by Western blot analysis. Representative image from three
independent experiments is shown along with β-actin for internal loading control. (C) HepG2 cells were incubated with the indicated concentrations of gAcrp for 24 h followed
by stimulation with ethanol for additional 24 h. Caspase-3 activity was determined as described in the Material and methods section. Values shown are the results of
three independent experiments and are expressed as mean ± SEM. ⁎P b 0.05 compared with cells not treated with ethanol; #P b 0.05 compared with cells treated with ethanol.
(D) Hepatocytes were isolated from rat and incubated with the indicated concentrations of gAcrp for 24 h followed by stimulation with ethanol for additional 24 h. Caspase-3
activity was determined as described previously. Values shown are the results of three independent experiments and are expressed as mean ± SEM. ⁎P b 0.05 compared with
cells not treated with ethanol; #P b 0.05 compared with cells treated with ethanol.
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Fig. 3. Role of induction of autophagy in the prevention of ethanol-induced apoptosis by globular adiponectin in HepG2 cells. (A) Cells were pretreated with the indicated concentration
of rapamycin for 2 h followed by incubation with ethanol for 24 h. Caspase-3 activity was determined as described in the Material and methods section. Values represent fold increase
compared to control and are expressed as mean ± SEM (n = 3). ⁎P b 0.05 compared with cells not treated with ethanol; #P b 0.05 compared with cells treated with ethanol.
(B) Cells were pretreated with the indicated concentration of 3-MA used as an inhibitor of autophagy in the absence or presence of gAcrp for 24 h followed by further stimulation
with ethanol for 24 h. Caspase-3 activity was determined as described previously and values represent fold increase compared to control of three independent experiments and are
expressed as mean ± SEM. ⁎Pb0.05 compared to cells not treated with ethanol; #Pb0.05 compared with ethanol-treated group; $P b 0.05 compared with cells treated with gAcrp and
ethanol. (C) Cells were transfected with siRNA targeting LC3B or scrambled control siRNA. After 24 h incubation, cells were pretreated with gAcrp followed by stimulation with the
indicated concentration of ethanol for 24 h. Caspase-3 activity was then measured as described previously. (D) Cells were transfected with siRNA targeting LC3B or scrambled control
siRNA. After 48 h incubation, cells were pretreated with gAcrp followed by stimulation with the indicated concentration of ethanol for 24 h. Cell viability was measured by MTS assay
as described in theMaterial andmethods section. Values shown are results of three independent experiments and are expressed asmean ± SEM. ⁎P b 0.05 compared to cells not treated
with ethanol; #P b 0.05 compared with cells treated with ethanol; $P b 0.05 compared with cells treated with gAcrp but not transfected with siRNA of LC3B. EtOH: Ethanol, gAcrp:
globular adiponectin.
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induced apoptosis inHepG2 cells. Next, to further determinewhether au-
tophagy plays a role in the suppression of ethanol-induced apoptosis by
gAcrp, cells were pretreated with 3-methyl adenine (3-MA), a class III
phosphoinositol 3-kinase (PI3K) inhibitor widely used as an inhibitor of
autophagy, and caspase-3 activity was measured. Interestingly, pretreat-
ment of cells with 3-MA restored caspase-3 activity suppressed by gAcrp
in ethanol-treated cells (Fig. 3B), providing evidence that gAcrp-induced
autophagy may play a role in the suppression of ethanol-induced
caspase-3 activity in HepG2 cells. The role of autophagy induction by
gAcrp in the inhibition of ethanol-induced apoptosis was conﬁrmed
by gene silencing of LC3B, which is a speciﬁc biomarker of cellular
autophagy. Importantly, knocking down the LC3B gene restored
caspase-3 activity suppressed by gAcrp to the normal level (Fig. 3C).
Interestingly, silencing of LC3 expression also abrogated enhancement
of cell viability by gAcrp in ethanol-treated cells (Fig. 3D). All these
data indicate that autophagy induction plays a critical role in the pre-
vention of ethanol-induced apoptosis by gAcrp.3.4. Globular adiponectin-induced autophagy causes suppression of
ethanol-induced Bax expression
Wenext investigatedmechanisms underlying prevention of ethanol-
induced apoptosis by induction of autophagy. Bax, a pro-apoptotic Bcl-2
family protein, is known to play a crucial role in the induction of apopto-
sis in ethanol-treated hepatocytes through activation of the intrinsic
pathway of apoptosis [36]. In the present study,we investigatedwhether
gAcrp regulates the intrinsic pathway of apoptosis by modulating
ethanol-induced Bax expression. For this, we ﬁrst examined the role of
autophagy in ethanol-induced Bax expression. As shown in Fig. 4A,
ethanol treatment increased Bax expression as expected (compare 1st
and 2nd column). The ethanol-induced increase in Bax protein expres-
sionwas signiﬁcantly reduced in the presence of rapamycin, an inhibitor
of mTOR and used as an autophagy inducer, implying that ethanol
may induce Bax protein expression via modulation of autophagy.
Furthermore, pretreatment with gAcrp also signiﬁcantly suppressed
ethanol-induced Bax protein expression (Fig. 4B). To further verify the
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Fig. 4. Role of autophagy induction by globular adiponectin in the suppression of ethanol-
induced Bax expression. (A) Cells were pretreated with indicated concentrations of
rapamycin for 24 h followed by stimulation with ethanol (50 mM) for 8 h. Bax protein
level was measured by Western blot analysis as described previously. Representative
images from three independent experiments are shown. (B) Cells were pretreated with
the indicated concentration of gAcrp for 24 h followed by incubation with ethanol
(50 mM) for 8 h. Bax protein level was determined as described previously. Representa-
tive images from three independent experiments are shown. (C) Cells were pretreated
with the indicated concentrations of 3-MA, an inhibitor of autophagy, and gAcrp for
24 h followed by further stimulation with ethanol for additional 8 h. Bax protein levels
were determined by Western blot analysis. Images shown are representative of three
independent experiments that showed similar results. (D) HepG2 cells were transfected
with siRNA targeting LC3B or scrambled control siRNA. After 48 h incubation, cells were
pretreatedwith gAcrp for 24 h and stimulatedwith ethanol (50 mM) for 8 h. Bax protein
level was then measured as described previously. 3-MA: 3-Methyl adenine.
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Fig. 5. Role of autophagy induction by globular adiponectin in the suppression of
ethanol-induced caspase-8 activation. (A) Cells were incubated with the indicated
concentration of ethanol for 24 h in the absence or presence of gAcrp and caspase-8
activity was measured as described in the Material and methods section. Values are
depicted as mean ± SEM (n = 3). ⁎P b 0.05 compared to control; #P b 0.05 compared
to ethanol-treated cells. (B) Cellswere transfectedwith siRNA targeting LC3B or scrambled
control siRNA for 48 h. After transfection, cells were incubated with gAcrp for 24 h
followed by treatment with ethanol for additional 24 h. Caspase-8 activity was then
measured as described previously. Values are shown as mean ± SEM, n = 3. ⁎P b 0.05
compared with control; #P b 0.05 compared with cells treated with ethanol; $P b 0.05
compared with cells treated with gAcrp and ethanol but not transfected with LC3B siRNA.
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induced Bax expression, cells were treated with gAcrp in the presence
or absence of 3-MA. As shown in Fig. 4C, pretreatment with 3-MA
reverted suppression of Bax protein expression by gAcrp in ethanol-
treated cells. Moreover, gene silencing of LC3B by siRNA restored
suppressive effect of gAcrp on ethanol-induced Bax protein expression
(Fig. 4D). Taken together, these data provide vital evidence that autoph-
agy induction by gAcrp plays a central role in the suppression of
ethanol-induced Bax expression.
3.5. Autophagy induction by globular adiponectin suppresses ethanol-
induced caspase-8 activation
Ethanol treatment has been shown to induce caspase-8 activation,
an integral component of the extrinsic pathway of apoptosis, in liver
cells [37]. We also examined whether autophagy induction by gAcrp
modulates caspase-8 activation in ethanol-treated HepG2 cells. As
shown in Fig. 5A, ethanol treatment caused a signiﬁcant increase incaspase-8 activity in HepG2 cells, and pretreatment with gAcrp
inhibited ethanol-induced caspase-8 activation, implying that gAcrp
inhibits ethanol-induced apoptosis in HepG2 cells through modulation
of the extrinsic pathway of apoptosis. Furthermore, knocking down
LC3B gene restored caspase-8 activity suppressed by gAcrp to a level
similar to that in cells treated with ethanol alone (Fig. 5B). Taken
together, these data suggest that gAcrp-induced autophagy plays a
putative role in the suppression of ethanol-induced apoptosis via mod-
ulation of the extrinsic pathways of apoptosis in HepG2 cells, as well as
intrinsic pathways (modulation of Bax).
3.6. AMPK signaling is implicated in expression of autophagy-related
genes and suppression of ethanol-induced caspase-3 activation by gAcrp
To further explore the potential signaling mechanisms involved in
gAcrp-induced expression of autophagy-related genes, we ﬁrst exam-
ined the role of AMPK in gAcrp-induced LC3B mRNA expression, since
AMPK activation mediates numerous biological responses by gAcrp
[19,26]. Knockingdown theAMPKgenebyAMPKα-1 siRNA transfection
signiﬁcantly decreased both gAcrp-induced LC3B mRNA (Fig. 6A, left
panel) and LC3 II protein (Fig. 6A, right panel) expression in HepG2
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expression. Next, we determined the role of AMPK in the restoration of
LC3B expression by gAcrp in ethanol-treated cells. As depicted in
Fig. 6B, AMPK gene silencing blocked the restoration of LC3B mRNA
(left panel) and LC3 II protein expression (right panel) by gAcrp in
ethanol-treated cells. The expression level of LC3 gene was similar to
that observed in cells treated with ethanol alone, implying that AMPK
signaling plays a critical role in the up-regulation of autophagy-related
gene expression by gAcrp in ethanol-treated cells. Moreover, confocal
microscopic analysis showed suppression of LC3 dots (punctuated
pattern) by AMPK silencing in gAcrp and ethanol-treated cells (Fig. 6C).
Finally, we aimed to verify the role of AMPK signaling in the suppression
of ethanol-induced caspase-3 activation by gAcrp in HepG2 cells. As
shown in Fig. 6D, gene silencing of AMPK blocked the protective effect
of gAcrp against ethanol-induced caspase-3 activation, suggesting that
AMPK signaling plays a cardinal role in the suppression of ethanol-
induced apoptosis by gAcrp.
3.7. FoxO3A signaling is involved in globular adiponectin-induced
expression of genes related with autophagy
FoxO family proteins translocate into the nucleus in response to
stimuli and cause transcriptional activation of target genes. FoxO family
transcription factors, particularly FoxO3A, are commonly associated
with induction of autophagy-related genes [30,31]. Thus, to further
characterize the transcription factor responsible for induction of
autophagy-related genes by gAcrp, we investigated the role of FoxO3A
in beclin-1 and LC3 expression. For this, we ﬁrst measured the subcellu-
lar localization of FoxO3A protein on gAcrp treatment. As shown in
Fig. 7A, gAcrp treatment decreased FoxO3A protein level in the cytosol,
whereas nuclear FoxO3A accumulation was increased in a time-
dependent manner. In addition, ethanol-treatment inhibited nuclear
translocation of FoxO3A, which was restored to normal levels by
gAcrp (Fig. 7B), suggesting that gAcrp causes activation of FoxO3A
that might play a role in the induction of autophagy-related genes.
Furthermore, transfection of FoxO3A siRNA signiﬁcantly inhibited
expression of autophagy-related proteins such as beclin-1 mRNA
(Fig. 7C), LC3B mRNA (Fig. 7D, left panel) and LC3 II proteins (Fig. 7D,
right panel) upon gAcrp treatment. In addition, gene silencing of
FoxO3A almost completely negated the up-regulation of beclin-1
(Fig. 7E) and LC3B (Fig. 7F) by gAcrp in ethanol-treated cells, providing
crucial evidence that FoxO3A plays a critical role in the gAcrp- induced
increase in the expression of autophagy-related genes in HepG2 cells.
Finally, to explore the involvement of AMPK activation in FoxO3A trans-
location to the nucleus, cells were transfected with AMPK α-1 siRNA
and nuclear FoxO3A protein levels were assessed by Western blot
analysis. Importantly, AMPK silencing signiﬁcantly decreased nuclear
FoxO3A protein level (Fig. 7G), suggesting that AMPK activation, at
least in part, plays a crucial role in the translocation of FoxO3A, which
contributes to induction of autophagy-related genes by gAcrp.
4. Discussion
Alcoholic liver disease (ALD) caused by excessive alcohol consump-
tion is a major cause of chronic liver disease throughout the world.
Despite advancements in our understanding of themechanisms underly-
ing ALD, targeted therapies for the management of ALD are still
unavailable. Among the broad spectrum of pathogenesis that constitutes
ALD, hepatocellular apoptosis is considered an important early response
of liver cells to hepatic injury [38]. Adiponectin, the most abundant
adipokine secreted from adipose tissue, has been shown to prevent
ethanol-induced liver injury in various experimental settings. In particu-
lar, a recent study has demonstrated that globular adiponectin (gAcrp)
inhibits ethanol-induced apoptosis in hepatoma cell lines [24]. A series
of recent studies have also indicated that autophagy counteracts
dysregulated apoptosis under conditions of stressful insults andpromotescellular survival [8,39]. Furthermore, alcohol consumption has been
linked to the inhibition of autophagic process in liver cells [15,17,18].
Therefore, in an attempt to elucidate themechanisms underlying the pro-
tection of liver cells from ethanol-induced cell death by adiponectin, we
investigated the effect of globular adiponectin on the autophagic process
in a human liver cell line and further delineated the role of autophagy in-
duction in the suppression of ethanol-induced apoptosis. In the present
study, we have demonstrated for the ﬁrst time that globular adiponectin
protects liver cells from ethanol-induced apoptosis through activation of
autophagy. Moreover, we have also presented that the AMPK-FoxO3A
signaling pathway plays a central role in the gAcrp-induced expression
of genes related to autophagy in liver cells and the prevention of
ethanol-induced apoptosis by globular adiponectin.
In the present study, we have demonstrated that gAcrp restores
autophagy suppressed by ethanol in liver cells. However, the effects
of ethanol on autophagy are controversial. Ding et al., demonstrated
that ethanol activates autophagy in mice liver and cultured liver cells
[17], and suggested that enhanced autophagy plays a protective role
against ethanol-induced liver damage, while many other previous
reports have shown that ethanol decreases autophagic process. For
example, Noh et al. [16] has shown that ethanol reduces autophagy in
rat hepatoma cell lines. Ethanol treatment has been also demonstrated
to inhibit expression of autophagy-related proteins in immune cells,
including humanmonocytic U937 and CD4 Jurkat cells [15], and inhibit
autophagic process inMCF-7 cells and neuronal cells [40,41]. It has been
shown that ethanol disrupts lysosomalmachinery and inhibits fusion of
autophagosome with lysosomes, a critical late step in autophagy pro-
cess for the degradation of misfolded proteins [42]. Recently, a review
paper has highlighted that oxidative stress and reactive oxygen species
(ROS) production during ethanol treatment can also impair autophagy
in liver cells. Similarly, ethanol treatment has been shown to impair
intrahepatic amino-acid pool that canmediate suppression of autophagy
[28]. Moreover, ethanol treatment has beenwell known to affect various
signaling pathways, such as JNK and AMPK in the liver that has potential
to impair autophagy in the liver cells [40,43]. Based on these controver-
sial reports, the exact effects of ethanol on autophagy are not conclusive,
and seem to depend on the experimental conditions, such as cell type,
origin of cell, incubation time and the way of treatment. At this stage,
while we cannot directly dissect the discrepancy on the different results
from the previous report by Ding et al.,[17], we found potential differ-
ences between Ding's et al., and our experiments. While we performed
our experiments on HepG2 cells and primary hepatocytes isolated
fromrats, Ding et al., used ethanol bingemodel inmice aswell as primary
hepatocytes from mice. We assume that this may be responsible for the
different responses.
In the present study, we demonstrated that ethanol suppresses the
expression of autophagy-related (Atg) genes in a human hepatoma
cell line and primary hepatocytes isolated from rat and that gAcrp
restores the ethanol-suppressed expression of Atg genes and proteins
at both mRNA and protein levels (Fig. 1A–F). Among various Atg
genes, beclin-1 and LC3 play a critical role in coordination of the
cytoprotective function of autophagywhile counteracting the apoptotic
process [44]. Beclin-1 has been suggested to play a cardinal role in
autophagosome formation through localization of autophagy-related
proteins to a pre-autophagosomal structure that is dependent on inter-
action with class III phosphoinositide 3-kinase/Vacuolar sorting protein
34 [44,45]. LC3, an important constituent of autophagosomes, also plays
an essential role in the fusion of autophagosomes with lysosomes
for degradation of damaged organelles by lysosomal enzymes [8],
suggesting that inducing expression of these genes is closely associated
with induction of the autophagic process by gAcrp.
It has been reported that there are direct interactions between
beclin-1 and Bcl-2 family members. Interestingly, the relationship
between autophagy and apoptosis is a matter of intense debate. The
important points in the interconnection between apoptosis and
autophagy include autophagy-induced suppression of caspase activity
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Many studies supported the notion that the apoptotic process usually
leads to the suppression of other cell death pathways such as autophagysc
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Cand necrosis [7], while other studies have suggested that the autophagic
process prevents apoptosis and subsequently protects cells from
various harmful stimuli. For example, a study by Xiao showed thatLC3 I
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Fig. 6. Involvement of AMPK signaling in globular adiponectin-induced autophagy-
related gene expression and attenuation of ethanol-induced caspase-3 activation in
HepG2 cells. (A) Cells were transfected with siRNA targeting AMPK or scrambled
control siRNA and treated with gAcrp (1 μg/ml) for 24 h. The level of LC3B mRNA
(left panel) and LC3II protein (right panel) was assessed as described previously. In
left panel, results are expressed as fold increase compared to control group and
shown as mean ± SEM of three independent experiments. *P b 0.05 compared with
control group; #P b 0.05 compared with cells treated with gAcrp but not transfected
with AMPK siRNA. (B) After transfection with siRNA targeting AMPK or scrambled
control siRNA, cells were pretreated with indicated concentration of gAcrp for 24 h
and then stimulated with ethanol for additional 24 h. LC3B mRNA(left panel) and
LC3II protein expression(right panel) was determined as described previously. Results
are expressed as fold increase compared to control group and shown as mean ± SEM
of three independent experiments. ⁎P b 0.05 compared with control group; #P b 0.05
compared with ethanol treated group, $P b 0.05 compared with cells treated with
gAcrp but not transfected with AMPK siRNA. (C) Cells were transfected with
eGFP-LC3 expression plasmid for 24 h followed by transfection with siRNA targeting
AMPK or scrambled control siRNA and treated with ethanol for 24 h in the absence
or presence of gAcrp. GFP-LC3 was viewed with A1 Confocal Laser Microscope as de-
scribed in materials and methods. Representative images from three independent ex-
periments are shown along with quantitation of LC3 dots on the lower panel. Values
are expressed as LC3 dots percentage of cells with GFP-LC3 dots obtained from at
least 100 cells. C: Control, E: ethanol, gAcrp: globular adiponectin. *P b 0.05
compared with cells not treated with ethanol; #P b 0.05 compared with cells treated
with ethanol. $P b 0.05 compared with cells treated with gAcrp and ethanol but not
transfected with siRNA targeting AMPK. (D) Cells transfected with AMPK siRNA were
pretreated with gAcrp (1 μg/ml) for 24 h and stimulated with ethanol for additional
24 h. Caspase-3 activity was then assessed as described in the Material and methods
section. Data are expressed as fold change relative to control group. Values are
shown as mean ± SEM, n = 5. ⁎P b 0.05 compared with control group; #P b 0.05
compared with cells treated with ethanol; $P b 0.05 compared with cells treated with
gAcrp and ethanol but not transfected with siRNA of AMPK.
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survival role of autophagy is optimally manifested in conditions associ-
ated with cell death that may occur simultaneously [47]. It has been
reported that adiponectin protects the liver from ethanol-induced
damage [23] and inhibits ethanol-induced apoptosis [24]. Even though
a close (negative) relationship between autophagy and apoptosis has
beenpreviously suggested, the role of autophagy in the hepatoprotective
effect of adiponectin has not been explored. The current study clearly
demonstrates for the ﬁrst time that gAcrp induces an increase in the
expression of autophagy-related genes and that the gAcrp-induced
autophagic process plays an important role in the amelioration of
ethanol-induced apoptosis.
The results presented in current study are in agreement with recent
studies showing that adiponectin inhibits ethanol-induced apoptosis
through modulation of heme oxygenase-1 (HO-1) [24] and activation
of autophagy mediated by HO-1 contributes to prevention of hepatic
cell death from infection/sepsis in mice [48]. HO-1 is implicated in
adiponectin-induced protective actions in various pathophysiological
conditions. Data presented here and in previous studies further suggest
a possible role of HO-1 in adiponectin-induced autophagy and protec-
tion of cells from various stimuli. It would be interesting to furtherelucidate themolecularmechanisms underlying how autophagy activa-
tion by gAcrp prevents ethanol-induced cell death in liver cells.
Dysregulated autophagy is closely associated with a number of
disease conditions. In particular, autophagy increases the threshold for
death stimuli in many cellular conditions [49] and the survival advan-
tage offered by autophagy in cells undergoing apoptosis has important
implications in the pathogenesis of several human diseases including
alcoholic liver disease and cancer [18,46]. In fact, Habeeb et al. recently
reported that adiponectin supports survival of colorectal cancer cells in
glucose-deprived conditions by enhancing autophagy [50]. However,
less attention has beenpaid regarding the role of autophagy inmediating
adiponectin-induced various biological responses. In the current study,
we have demonstrated a crucial role of autophagy in theprotective effect
of adiponectin against ethanol-induced cell death. This is the ﬁrst report,
to our knowledge, showing a role for the autophagic process in the
protective response by adiponectin from a certain harmful stimulus.
Data presented here suggest that the autophagic process would be a
promising target mediating various biological functions of adiponectin
and, indeed, our results have opened up a new research area for identify-
ing the role of autophagy in diverse biological responses of adiponectin.
AMP-dependent protein kinase (AMPK) acts as a sensor of cellular
energy level and its activity is regulated by various cellular stresses
such as hypoxia, glucose deprivation, and oxidative stress [26]. The
activation of AMPK increases the catabolic process inside the cells,
which modulates numerous pathophysiological processes. It has now
been ﬁrmly established that many beneﬁcial biological responses
induced by adiponectin are attributed to AMPK activation and its
downstream transcriptional mediators [19,30]. A recent study by
Katsiougiannis et al. revealed that the anti-apoptotic effect of
adiponectin is mediated by AMPK activation in salivary gland epithelial
cells [51]. Furthermore, AMPK activation is essential for the induction
of autophagy in hepatocytes, Hela cells and HT-29 cells [52]. A number
of studies have also shown that ethanol decreases AMPK activity in
the liver [43,49]. Based on these previous reports, we hypothesized
that AMPK signaling is involved in the induction of autophagy by
adiponectin and plays a critical role in the prevention of ethanol-
induced apoptosis. The results shown in the current study clearly dem-
onstrate that modulation of AMPK plays a key role in the regulation of
the autophagic process in HepG2 cells treated with gAcrp and ethanol.
AMPK mediates various biological responses through modulation of
downstream targets, particularly via regulation of various transcription
factors. Chiacchirea et al. reported that AMPK activation causes nuclear
translocation of Forkhead box O3A (FoxO3A), thereby inducing expres-
sion of genes involved in autophagy [53]. We also demonstrated that
knocking down FoxO3A prevents gAcrp-induced expression of beclin-
1 and LC3 (Fig. 7C andD), while gene silencing of AMPK prevents nucle-
ar translocation of FoxO3A (Fig. 7G) and expression of LC3 (Fig. 6A and
B), indicating that the AMPK/FoxO3A axis plays a critical role in the
prevention of ethanol-induced apoptosis in HepG2 cells. Emerging
evidence has demonstrated that the FoxO3A transcription factor is im-
plicated in various biological responses, including tumor suppression,
development and energy metabolism [54]. Adiponectin has been also
shown to regulate many of these responses. Even if there is no report
regarding the role of FoxO3A in mediating adiponectin-induced biolog-
ical responses, it is highly likely that FoxO3A is the transcription factor
that mediates autophagic responses by adiponectin. The data presented
here suggest that FoxO3A is a promising target mediating various bio-
logical responses induced by adiponectin.
Ethanol treatment induces apoptosis of liver cell through modula-
tion of extrinsic and intrinsic pathways of apoptosis. Previous studies
have demonstrated that pro- and anti-apoptotic members of Bcl-2
family play a critical role in the intrinsic pathway of apoptosis. In partic-
ular, expression of Bax, a pro-apoptotic protein, activates apoptotic
process in ethanol-treated hepatocytes and many other experimental
conditions [36,55]. It translocates into mitochondria from cytosol upon
sensing various cell death stimuli and initiates efﬂux of cytochrome c,
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Fig. 7. Role of AMPK-FoxO3A signaling in expression of autophagy-related genes by globular adiponectin in HepG2 cells. (A) Cells were incubated with gAcrp (1 μg/ml) for the
indicated time periods. Cytosolic and nuclear fractions were prepared as described in the Material and methods section and the level of FoxO3A protein in each fraction was
determined by Western blot analysis. β-actin and lamin b1 was used as an internal control for cytosolic and nuclear fractions. Images are representative of three independent
experiments that showed similar results. (B) Cells were pretreated with the indicated concentration of gAcrp for 24 h then treated with ethanol (50 mM) for additional 24 h. Cytosolic
and nuclear FoxO3A protein levels were determined byWestern blot analysis as described previously. Images shown are representative of three independent experiments that showed
similar results. (C) Cells were transfectedwith siRNA targeting FoxO3A or scrambled control siRNA for 48 h andwere treatedwith gAcrp (1 μg/ml) for 24 h. Beclin-1 expression level was
determined by qRT-PCR as described previously. Values are expressed as mean ± SEM (n = 5). ⁎P b 0.05 compared with control group; #P b 0.05 compared with cells treated with
gAcrp but not transfected with FoxO3A siRNA. (D) Cells were transfected with siRNA targeting FoxO3A or scrambled control siRNA for 48 h and were treated with gAcrp (1 μg/ml) for
24 h. In left panel, LC3B mRNA level was determined by qRT-PCR. Values are expressed as mean ± SEM (n = 5). ⁎P b 0.05 compared with control group; #P b 0.05 compared with
cells treated with gAcrp but not transfected with FoxO3A siRNA. In right panel, LC3 II protein expression level was determined by Western blot analysis. (E) Cells were transfected
with siRNA targeting FoxO3A or scrambled control siRNA for 48 h. Cells were pretreated with gAcrp (1 μg/ml) for 24 h and then treated with the indicated concentration of ethanol
stimulation for additional 24 h. Beclin-1mRNA levelwasdetermined by qRT-PCR as describedpreviously. Values shown are the results ofﬁve independent experiments and are expressed
as mean ± SEM. ⁎P b 0.05 compared with control group; #P b 0.05 compared with cells treated with ethanol; $P b 0.05 compared with cells treated with ethanol and gAcrp but not
transfected with siRNA of FoxO3A. (F) Cells were transfected with siRNA targeting FoxO3A or scrambled control siRNA for 48 h. Cells were pretreated with gAcrp (1 μg/ml) for 24 h
and then treated with the indicated concentration of ethanol stimulation for additional 24 h. In left panel, LC3B mRNA level determined by qRT-PCR. Values shown are the results of
ﬁve independent experiments and are expressed as mean ± SEM. ⁎P b 0.05 compared with control group; #P b 0.05 compared with cells treated with ethanol; $P b 0.05 compared
with cells treated with ethanol and gAcrp but not transfected with siRNA of FoxO3A. In right panel, LC3 II protein expression level was determined byWestern blot analysis as described
previously. (G) After transfectionwith siRNA targeting AMPKor scrambled control siRNA, cells were treatedwith gAcrp (1 μg/ml) for 24 h and FoxO3A protein levelswere determined by
Western blot analysis as described previously. Images are representative of three independent experiments that showed similar results. β-actin and lamin b1 was used as an internal
control.
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caspase-3 [4,55]. Furthermore, a number of studies have implicated
Bax in the balance between autophagy and apoptosis [7,56]. Previous
studies have shown that over-expression of Bax inhibits autophagy by
degrading beclin-1 [57], while a credible role of autophagy in the
suppression of Bax expression has been shown in human glioma cells
treated with arsenic trioxide [58] and in cardiac myocytes undergoing
ischemia-reperfusion injury [12]. The current study reinforced these
ﬁndings that autophagy may counteract apoptosis as evidenced by
suppression of ethanol-induced Bax protein expression by treatment
with rapamycin, an inducer of autophagy (Fig. 4B). The results from
induction of autophagy and its role in the suppression of ethanol-
induced Bax protein expression (Fig. 4C–E) intriguingly suggest that
autophagy may have a more dominant role than apoptosis in the regu-
lation of cell death in HepG2 cells treatedwith globular adiponectin. Bax
is implicated in the initiation of the intrinsic pathway of apoptosis,
suggesting that gAcrp efﬁciently rescues cell death by acting on the
intrinsic pathway of apoptosis.
Ethanol treatment also causes activation of the extrinsic pathway of
apoptosis. In ethanol-treated cells, the extrinsic pathway of apoptosis isinitiated by binding of FasL and/or TNF-α to its receptors followed by
recruitment of its death domain and ultimately activation of caspase-8
and downstream effectors, including caspase-3 [4]. The data presented
in the current study also showed that gAcrp signiﬁcantly suppresses
ethanol-induced activation of caspase-8, an important modulator of
extrinsic pathway of apoptosis (Fig. 5A), corroborating earlier ﬁndings
that adiponectin regulates the extrinsic pathway of apoptosis in the
suppression of ethanol-induced apoptosis [24]. Our study further
showed that inhibition of autophagy negates the suppressive effect
of adiponectin on ethanol-induced activation of caspase-8 (Fig. 5B),
which is in agreement with a previous study showing that autophagy
counter-balances the apoptotic response through inhibition of
caspase-8 activity in human colon cancer cells (HCT116) that are
TRAIL-resistant [14]. Therefore, it is reasonable to speculate that induc-
tion of autophagy by gAcrp might prevent ethanol-induced apoptosis
bymodulating ethanol-induced activation of caspase-8. Taken together,
these data imply that gAcrp suppresses ethanol-induced apoptosis
throughmodulation of the extrinsic and intrinsic pathways of apoptosis.
With regards to the role of LC3B in autophagy induction and sup-
pression of apoptosis, it has been recently reported that LC3B interacts
LC3B, 
Beclin-1
Bax
FoxO3A
Caspase-8
EtOH
gAcrp
APOPTOSIS
Caspase-3
AMPK
Cyt.C
Fig. 8. Proposed model for the activation of autophagy by globular adiponectin and its
protective effect against ethanol-induced apoptosis in HepG2 cells. Ethanol treatment
causes aberrant apoptosis of liver cells. This is modulated by both the intrinsic
pathway, which is regulated by Bcl-2 family members including Bax, and the extrinsic
pathway, which is mediated by activation of caspase-8. Activation of both pathways ul-
timately leads to activation of caspase-3, the executioner of apoptosis. Globular
adiponectin induces nuclear translocation of FoxO3A in an AMPK-dependent manner.
AMPK/FoxO3A signaling plays a key role in gAcrp-induced expression of genes
involved in the autophagic process, such as Beclin-1 and LC3B. Importantly, gAcrp-
induced autophagy plays an important role in the prevention of ethanol-induced
apoptosis in liver cells through modulation of both the extrinsic and intrinsic pathways
of apoptosis. Detailed mechanisms underlying inhibition of the intrinsic and extrinsic
pathways of apoptosis by gAcrp-induced autophagy remain to be determined. Cyt.
C: Cytochrome C, EtOH: Ethanol, gAcrp: Globular adiponectin.
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thelial cells [59]. This report suggests that LC3B canmodulate apoptotic
process through physical interaction with apoptotic inducer, as well as
induction of autophagy. Although we don't have direct evidence for
the interaction of LC3 with Fas and its functional role in themodulation
of apoptosis in this experimental condition, we have used various phar-
macologicalmodulators of autophagy, such as baﬁlomycinA1, rapamycin
and 3-methyl adenine, apart from LC3B silencing experiments, to dissect
the involvement of autophagy induction by gAcrp in the suppression of
ethanol-induced apoptosis. Further, gene silencing of Atg5 also restored
suppression of caspase-3 activity by gAcrp (manuscript in preparation).
All these data suggest that autophagy induction by gAcrp plays a critical
role in the suppression of ethanol-induced apoptosis.
In conclusion, the data presented here demonstrate for the ﬁrst time
that globular adiponectin protects liver cells from ethanol-induced
apoptosis through modulation of autophagy and this protective effect
is mediated by AMPK and FoxO3A signaling (Fig. 8). The fate of the
cells is governed by the balance between apoptosis and autophagy. In
accordance with these ﬁndings, the pro-survival function of autophagy
induced by globular adiponectin likely plays a key protective role in
ethanol-induced cell death. Based on these ﬁndings, we suggest that
induction of autophagy by adiponectin would be a novel mechanism
for protection from chronic alcohol-induced liver injury. The aim of
the present study is to understand themechanisms underlying suppres-
sion of apoptosis by adiponectin in ethanol-treated liver cells, thus we
have performed initial and critical experiments using primary rat hepa-
tocytes, but not all the experiments. Further studies are now required to
validate ourﬁndings in HepG2 cells into normal hepatocytes and its role
in the prevention of alcoholic liver disease in an in vivo model.
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